Feedback
Settings

Settings

Goto Application

1. RU0002742333 - OXYSTEROLES AND METHODS OF USING THEM

PermaLink
Office
Russian Federation
Application Number 2018104245
Application Date 06.07.2016
Publication Number 0002742333
Publication Date 07.08.2019
Grant Number
Grant Date 04.02.2021
Publication Kind C2
IPC
A61K 31/575
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
575substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
C07J 9/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
JSTEROIDS
9Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
A61P 25/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
20Hypnotics; Sedatives
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
CPC
C07J 9/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
JSTEROIDS
9Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
C07J 17/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
JSTEROIDS
17Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
A61P 23/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
23Anaesthetics
A61P 1/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 1/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
10Laxatives
A61P 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Inventors САЛИТУРО Франческо Г. (US)
РОБИШО Альбер Жан (US)
МАРТИНЕС БОТЕЛЬЯ Габриэль (US)
ХАРРИСОН Бойд Л. (US)
SALITURO, Francesco, G. (US)
ROBICHAUD, Albert, Jean (US)
MARTINEZ BOTELLA, Gabriel (US)
HARRISON, Boyd, L. (US)
Priority Data 62/189,068 06.07.2015 US
62/332,931 06.05.2016 US
Title
(EN) OXYSTEROLES AND METHODS OF USING THEM
front page image
Abstract
(RU) Изобретение относится к соединению формулы (I-C-i) или его фармацевтически приемлемым солям. В формуле (I-C-i) R1 является C1-6 алкилом и R2 является -CH2CF3, этилом, изопропилом или циклопропилом. Изобретение также относится к фармацевтической композиции и способу положительного аллостерического модулирования NMDA-рецептора. Технический результат: получены новые соединения формулы (I-C-i), которые обладают свойством положительного аллостерического модулятора NMDA и могут применяться при лечении NMDA-опосредованных нарушений. 3 н. и 14 з.п. ф-лы, 1 табл., 39 пр.
Related patent documents
AU2016289971
PE2018-0482
KR1020180026742
EP3319612
CN108135911
US20180194797
MYPI 2018000010
ID2018/07784
PH1/2018/500061
BR112018000205
JP2018519328
WO/2017/007840
SG10202002655V
EP3812392
RU2021100377
NZ777721
DK3319612
LT3319612
PT3319612
RS62220
CN113501855
MA42411
ES2884086
PLWO2017007840
IL256531
IN201817000161
CA2991313
SG11201800054XThis application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
NZ738849
MX2018000280
CO20180000589
CONC2020/0015114This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
BR122021005567This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
PH12020551586This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
JP2021046444
IL282048
US20220048943
AU2021218230
IL289976
# -